Deals
StemCells Raises $20M at 12% Discount via Ascendiant Capital Markets
|
StemCells, Inc. (STEM) announced that it has raised $20,000,000 in a Units (Common Stock + Warrants) transaction.
Growth Capitalist (https://growthcapitalist.com/tag/biotech/page/61/)
StemCells, Inc. (STEM) announced that it has raised $20,000,000 in a Units (Common Stock + Warrants) transaction.
Equity private placement investors and emerging growth companies continued a brisk pace of deal making in the first half of 2014, maintaining momentum generated by a robust but toppy stock market and a growing appetite for risk.
Tonix Pharmaceuticals Holding Corporation (TNXP) announced that it has raised $7,818,300 in a Registered Direct transaction.
Ocera Therapeutics, Inc. (OCRX) announced that it has raised $25,200,000 in a CMPO/Overnight transaction.